Physician profile
Stuart L Blum
NPI 1073509535
$1,954.88
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,503 · 2020: $347 · 2021: $22.15 · 2022: $82.76.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $342.14 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $275.96 | 2019 | |
| Pfizer INC. | $264.21 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $167.84 | 2019-2020 | |
| Amgen INC. | $155.42 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $146.33 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $143.67 | 2019-2020 | |
| Akcea Therapeutics, INC. | $101.26 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $80.63 | 2019 | |
| Astellas Pharma US INC | $41.45 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $40.95 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $36.68 | 2019 | |
| Abiomed | $34.22 | 2019-2021 | |
| Irhythm Technologies, INC. | $32.59 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $29.07 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Preventice Services, LLC | $20.82 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $16.76 | 2019 | |
| Medtronic Vascular, INC. | $13.18 | 2019 | |
| Amarin Pharma, INC. | $11.70 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Blum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.